ROP
60
-5
COF
58
5
QCOM
57
2
LMT
45
-4
EXPD
54
7
CHD
56
-2
ETR
71
2
AIG
53
2
AIV
62
-3
EXC
54
-2
NTRS
49
2
BSX
69
-2
ZION
52
2
HCA
70
-3
APA
25
4
RHI
52
2
PYPL
47
2
WFC
58
3
CME
59
-2
FAST
48
2
ROP
60
-5
COF
58
5
QCOM
57
2
LMT
45
-4
EXPD
54
7
CHD
56
-2
ETR
71
2
AIG
53
2
AIV
62
-3
EXC
54
-2
NTRS
49
2
BSX
69
-2
ZION
52
2
HCA
70
-3
APA
25
4
RHI
52
2
PYPL
47
2
WFC
58
3
CME
59
-2
FAST
48
2
Financhill
Back

AstraZeneca PLC 10K Form

Buy
53

AZN
AstraZeneca PLC

Last Price:
78.58
Seasonality Move:
2.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AZN News And Ratings

See the #1 stock for the next 7 days that we like better than AZN

AZN Financial Statistics

Sales & Book Value

Annual Sales: $45.81B
Cash Flow: $2.42B
Price / Cash Flow: 35.21
Annual Sales: $12.74
Price / Book: 6.16

Profitability

EPS (TTM): 2.07000
Net Income (TTM): $6.44B
Gross Margin: $37.54B
Return on Equity: 16.87%
Return on Assets: 6.44%

AstraZeneca PLC Earnings Forecast

Key AstraZeneca PLC Financial Ratios

  • The Gross Profit Margin over the past 26 years for AZN is 81.95%.
  • The Selling, General & Administrative Expenses for AZN have been equal to 39.78% of Gross Profit Margin.
  • The Research & Development expenses have been 23.87% of Revenue.
  • The Interest Expense is 26.68% of Operating Income.
  • The Net Earning history of AZN is 13.00% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 20 years.

AstraZeneca PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AZN
CUSIP: 046353
Website: astrazeneca.com

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 0.89
Quick Ratio: 0.69

Price-to-Earnings

Trailing P/E Ratio: 41.22
Forward P/E Ratio: 16.81

AZN Technical Analysis vs Fundamental Analysis

Buy
53
AstraZeneca PLC (AZN) is a Buy

Is AstraZeneca PLC a Buy or a Sell?

  • AstraZeneca PLC stock is rated a Buy
    The current AstraZeneca PLC [AZN] share price is $78.53. The Score for AZN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.